Last year I engineered an advanced agentic AI pharma strategy development application. One year later, after many ...

The round was led by Surface Ventures, with participation from Remarkable Ventures, and follows a prior investment from the ...

Converteo, a leading consulting firm specializing in data and artificial intelligence, today announces the launch of a service and solution offering for production-grade AI dedicated to the Pharma & ...

NVIDIA Corp. NVDA expanded its presence in life sciences AI through separate initiatives with Certara Inc. CERT and Silo ...

Patent-Pending Multi-Agent Architecture Targets Fragmented Biomedical Data and Expands Toward Imaging, Omics, and Broader Health-Data Applications Ahead of Planned AAIC 2026 Demonstration in London ...

Members also reviewed plans to enhance regulatory operations to strengthen drug security and improve preparedness for global ...

Labviva, the intelligent procurement platform purpose-built for life sciences R&D, today announced the debut of The Agentic Crew , a first-of-its-kind agentic AI architecture that pairs specialized ...

Start narrow, build in guardrails, and plan to monitor for years – that was the consensus at a USEReady-hosted executive gathering in New Jersey. Pharma is not slow to adopt AI – it is slow to adopt ...

withZeta.ai is positioned as a force multiplier for the entire biomedical and drug development community — enabling investigators, R&D teams, biopharma companies, and global pharma enterprises to ...

Rolled out across all markets where Converteo operates (France, Italy, Spain, the United States, and Canada), this new offering enables healthcare players to automate their complex workflows and ...